Skip to main content

Magneto-Plasmonic, Raman active Nanocapsules for Superior Pediatric Brain Cancer Therapy

Project description

Theranostic nanoparticles against paediatric brain cancer

Theranostics is an emerging field of medicine that allows the combination of diagnosis, treatment and therapy follow-up. A theranostic approach for cancer therapy would reduce delays in treatment and offer a more targeted and personalised strategy. Importantly, it could be directed against tumours of the central nervous system that are otherwise hard to reach by standard chemotherapies. The EU-funded SUPERBRAIN project is developing a nanocapsule that combines a tumour-targeting molecule, a chemotherapeutic agent and photothermal therapy. The nanoparticles are magnetically guided in vivo, and they can be traced using imaging technologies. Moreover, they provide the opportunity to characterise the tumour and visualise the anatomy of the brain.

Coordinator

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Net EU contribution
€ 224 933,76
Address
Wellington Square University Offices
OX1 2JD Oxford
United Kingdom

See on map

Region
South East (England) Berkshire, Buckinghamshire and Oxfordshire Oxfordshire
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00